Age-Dependent Formation of TMEM106B Amyloid Filaments in Human Brain

Manuel Schweighauser, Diana Arseni, Melissa Huang, Sofia Lövestam, Yue‐De Yang, Wenjuan Zhang, Abhay Kotecha, Holly J. Garringer, Rubén Vidal, Grace I. Hallinan, Kathy L. Newell, Airi Tarutani, Shigeo Murayama, Masayuki Miyazaki, Yuko Saito, Mari Yoshida, Kazuko Hasegawa, Tammaryn Lashley, Tamás Révész, Gábor G. Kovács, John C. van Swieten, Masaki Takao, Masato Hasegawa, Bernardino Ghetti, Benjamin Falcon, Alexey G. Murzin, Michel Goedert, Sjors H. W. ScheresbioRxiv 2021 · DOI

TL;DR

This study reveals that the lysosomal protein TMEM106B forms amyloid filaments in the human brain, independent of specific neurodegenerative diseases. These filaments appear to form in an age-dependent manner, suggesting a novel, non-pathological aging process in the brain.

What Problem Does This Paper Address?

Many age-related neurodegenerative diseases, such as Alzheimer's and Parkinson's, are characterized by the accumulation of misfolded protein aggregates called amyloid filaments. While the amyloid filaments formed by proteins like tau, amyloid-beta (Aβ), and alpha-synuclein are well-studied and often linked to specific diseases, the full spectrum of amyloid formation in the aging brain remains incompletely understood. This paper investigates whether other proteins, particularly those involved in cellular processes like lysosomal function, can also form amyloid filaments and if this formation is tied to disease or simply aging.

Methods

The researchers employed electron cryo-microscopy (cryo-EM) to determine the atomic structures of TMEM106B filaments extracted from human brain tissue. This technique involves flash-freezing samples and imaging them with an electron microscope to visualize their three-dimensional structure at high resolution. They also used sarkosyl extraction to isolate insoluble protein aggregates from brain tissue, a standard method for enriching amyloid filaments. Immunoblotting was used to detect specific protein fragments, confirming the presence of TMEM106B in these aggregates.

Datasets

The study utilized brain tissue samples from 22 individuals diagnosed with various neurodegenerative conditions (including tauopathies, Aβ-amyloidoses, synucleinopathies, and TDP-43opathies) and 2 neurologically normal individuals. The age range of the neurologically normal individuals was crucial for determining the age-dependent nature of TMEM106B filament formation.

Key Insights and Ideas

  • TMEM106B as a Novel Amyloid Former: The most significant finding is that TMEM106B, a protein localized to lysosomes, can form amyloid filaments in the human brain, similar to well-known disease-associated proteins.
  • Disease Independence: Unlike many other amyloid proteins, the formation of TMEM106B filaments did not show a clear correlation with specific neurodegenerative diseases. This suggests TMEM106B aggregation might be a more general phenomenon.
  • Age-Dependent Formation: Crucially, TMEM106B filaments were found in older, neurologically normal individuals but not in younger ones, strongly indicating that their formation is linked to the aging process itself, rather than solely pathological conditions.
  • Structural Polymorphism: The study identified three distinct structural "folds" for TMEM106B filaments, highlighting the inherent variability in how proteins can misfold into amyloid structures.

Key Results

  • Cryo-EM structures revealed that residues 120-254 of TMEM106B form the ordered core of amyloid filaments.
  • Three distinct protofilament folds (folds I, II, and III) were identified, with fold I being the most common.
  • The presence of TMEM106B filaments correlated with a 29 kDa sarkosyl-insoluble fragment of the protein detected by Western blot.
  • TMEM106B filaments were observed in the brains of individuals with various neurodegenerative diseases and in older, but not younger, neurologically normal individuals.

Limitations and Future Work

The authors acknowledge that the precise role of TMEM106B filaments in the brain, particularly in relation to aging and potential disease mechanisms, requires further investigation. They suggest that, similar to lipofuscin (an age-related cellular aggregate), TMEM106B filaments might form within lysosomes. Future research should focus on determining if these filaments are present in tissues other than the brain and elucidating their functional consequences during aging and in various pathologies. The study also notes that while distinct TMEM106B folds were observed, they did not clearly characterize different diseases, suggesting that fold variation might be more related to structural constraints or other factors.

Summary updated

Abstract

Summary Many age-dependent neurodegenerative diseases, like Alzheimer’s and Parkinson’s, are characterised by abundant inclusions of amyloid filaments. Filamentous inclusions of the proteins tau, amyloid-β (Aβ), α-synuclein and TDP-43 are the most common. Here, we used electron cryo-microscopy (cryo-EM) structure determination to show that residues 120-254 of the lysosomal type II transmembrane protein 106B (TMEM106B) also form amyloid filaments in the human brain. We solved cryo-EM structures of TMEM106B filaments from the brains of 22 individuals with neurodegenerative conditions, including sporadic and inherited tauopathies, Aβ-amyloidoses, synucleinopathies and TDP-43opathies, as well as from the brains of two neurologically normal individuals. We observed three different TMEM106B folds, with no clear relationship between folds and diseases. The presence of TMEM106B filaments correlated with that of a 29 kDa sarkosyl-insoluble fragment of the protein on Western blots. The presence of TMEM106B filaments in the brains of older, but not younger, neurologically normal individuals indicates that they form in an age-dependent manner.
BibTeX
@misc{schweighauser2021age,
  author = {Manuel Schweighauser and Diana Arseni and Melissa Huang and Sofia Lövestam and Yue‐De Yang and Yang Yang and Wenjuan Zhang and Abhay Kotecha and Holly J. Garringer and Rubén Vidal and Grace I. Hallinan and Kathy L. Newell and Airi Tarutani and Shigeo Murayama and Masayuki Miyazaki and Yuko Saito and Mari Yoshida and Kazuko Hasegawa and Tammaryn Lashley and Tamás Révész and Gábor G. Kovács and John C. van Swieten and Masaki Takao and Masato Hasegawa and Bernardino Ghetti and Benjamin Falcon and Alexey G. Murzin and Michel Goedert and Sjors H. W. Scheres},
  title = {{Age-Dependent Formation of TMEM106B Amyloid Filaments in Human Brain}},
  year = {2021},
  doi = {10.1101/2021.11.09.467923},
  howpublished = {bioRxiv},
}
Figure